SonoTarg ‘Wow’s’ King

An exciting end to last week for SonoTarg saw King Charles III visiting our laboratories to learn about the ground-breaking research into cancer therapies currently underway.

With SonoTarg planning first in-human trials later in 2025 the timely visit by the King provided the opportunity to demonstrate SonoTarg’s transformative microbubble and sonodynamic therapy. The King raised his eyebrows in astonishment at hearing how it worked and was heard to say ‘wow’ during the demonstration.

For more information and opportunities to invest in this pioneering treatment, please contact: david@sonotarg.com